Antibiotic. Injectable solution for cattle.
Each 100 mL contains: Tilmicosin, 30 g; excipients, q.s.f. 100 mL.
It is indicated for the treatment of respiratory disease in cattle, mainly associated to shipping fever, caused by Mannheimia haemolytica (Pasteurella haemolytica), treatment of infectious pododermatitis, pneumonia in calves and bovine infectious keratoconjunctivitis (BIK). The etiological agents susceptible to MAXITYL® are: Mannheimia (Pasteurella) haemolytica; Pasteurella multocida; Histophilus somni (Haemophilus somnus); Mycoplasma dispar; Mycoplasma bovis; Staphyloccocus aureus; Streptoccocus agalactiae; Actinomyces pyogenes; Actinobacillus pleuropneumoniae; Moraxella bovis; Clostridium perfringens; Fusobacterium necrophorum.
5 to 10 mg/kg of body weight, equivalent to 1 mL of MAXITYL® per 30 to 60 kg of body weight, according to the practicing veterinarian’s criterion. MAXITYL® is administered to cattle in subcutaneous tissue only in the neck or behind the shoulder blade, with regular syringes and 12/18 gauge needles. Do not use in auto injectors.
DO NOT ADMINISTER ENDOVENOUSLY- ENDOVENOUS INJECTION OF THIS PRODUCT HAS BEEN SHOWN TO BE FATAL.
Pneumonia: 1 mL/30 kg of body weight.
Pododermatitis: 1 mL/60 kg of body weight.
Keratoconjunctivitis: 1 mL/60 kg of body weight.
Usually single doses are used. If symptoms do not recede after 48 hours, reevaluate diagnosis.
For cattle only. Do not use in other species since it may be lethal. Handle with care, accidental injection may result in death.
Withdrawal period from last treatment until slaughter for human consumption is 28 days. Do not administer to dairy cattle whose milk is intended for human consumption or industrialization.
Bottles containing 20 mL and 100 mL.